nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry
|
Abou-Ismail, Mouhamed Yazan |
|
|
8 |
3 |
p. 620-623 |
artikel |
2 |
A leap in recognizing drug-induced immune hemolytic anemia
|
Hansen, Dennis Lund |
|
|
8 |
3 |
p. 815-816 |
artikel |
3 |
A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AML
|
Ravindran, Mithunan |
|
|
8 |
3 |
p. 629-639 |
artikel |
4 |
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines
|
Ghilardi, Guido |
|
|
8 |
3 |
p. 653-666 |
artikel |
5 |
Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
|
Ghobadi, Armin |
|
|
8 |
3 |
p. 513-522 |
artikel |
6 |
CARs for Hodgkin: engine fine-tuning is in order
|
Grover, Natalie S. |
|
|
8 |
3 |
p. 799-801 |
artikel |
7 |
Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease
|
Aumann, Megan A. |
|
|
8 |
3 |
p. 608-619 |
artikel |
8 |
Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperatives
|
Wicha, Sebastian G. |
|
|
8 |
3 |
p. 797-798 |
artikel |
9 |
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities
|
Hasselbalch, Hans Carl |
|
|
8 |
3 |
p. 681-682 |
artikel |
10 |
Clinical and immunological features in ACKR1/DARC-associated neutropenia
|
Palmblad, Jan |
|
|
8 |
3 |
p. 571-580 |
artikel |
11 |
Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency
|
Wang, Chen |
|
|
8 |
3 |
p. 603-607 |
artikel |
12 |
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation
|
Fuchs, Stijn N. R. |
|
|
8 |
3 |
p. 766-779 |
artikel |
13 |
Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
|
Watanabe, Mizuki |
|
|
8 |
3 |
p. 640-652 |
artikel |
14 |
Dave H, Terpilowski M, Mai M, et al. Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma. Blood Adv. 2022;6(2):473-485.
|
|
|
|
8 |
3 |
p. 683-685 |
artikel |
15 |
Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population
|
Joseph, Janine M. |
|
|
8 |
3 |
p. 538-548 |
artikel |
16 |
Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study
|
Maquet, Julien |
|
|
8 |
3 |
p. 817-826 |
artikel |
17 |
Evaluating self- vs interviewer-administered screening for depression in sickle cell disease
|
Lysandrou, Maria |
|
|
8 |
3 |
p. 699-702 |
artikel |
18 |
Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor
|
Fingerson, Stephanie |
|
|
8 |
3 |
p. 758-765 |
artikel |
19 |
Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial
|
Haverkos, Bradley |
|
|
8 |
3 |
p. 708-711 |
artikel |
20 |
Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms
|
Baranwal, Anmol |
|
|
8 |
3 |
p. 562-570 |
artikel |
21 |
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions
|
Bracken, Sonali J. |
|
|
8 |
3 |
p. 667-680 |
artikel |
22 |
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM
|
Rein, Alice Felicitas |
|
|
8 |
3 |
p. 712-724 |
artikel |
23 |
In utero hematopoietic cell transplantation leads to sustained engraftment in a mouse model of Fanconi anemia
|
Dave, Apeksha |
|
|
8 |
3 |
p. 624-628 |
artikel |
24 |
Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning
|
Zhou, Yiwang |
|
|
8 |
3 |
p. 686-698 |
artikel |
25 |
Ongoing production of tissue-resident macrophages from hematopoietic stem cells in healthy adult macaques
|
Rahmberg, Andrew R. |
|
|
8 |
3 |
p. 523-537 |
artikel |
26 |
Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis
|
Epperla, Narendranath |
|
|
8 |
3 |
p. 549-552 |
artikel |
27 |
Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure
|
Hrubesz, Gabriella |
|
|
8 |
3 |
p. 732-735 |
artikel |
28 |
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia
|
Lane, Andrew A. |
|
|
8 |
3 |
p. 591-602 |
artikel |
29 |
Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis
|
Vlachodimitropoulou, Evangelia |
|
|
8 |
3 |
p. 746-757 |
artikel |
30 |
R-Spondin1 protects gastric stem cells and mitigates gastric GVHD in allogeneic hematopoietic stem cell transplantation
|
Hayase, Eiko |
|
|
8 |
3 |
p. 725-731 |
artikel |
31 |
Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas
|
Shukla, Navika D. |
|
|
8 |
3 |
p. 780-784 |
artikel |
32 |
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML
|
Fein, Joshua A. |
|
|
8 |
3 |
p. 581-590 |
artikel |
33 |
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
|
Al Hadidi, Samer |
|
|
8 |
3 |
p. 703-707 |
artikel |
34 |
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism
|
Hatakeyama, Kiwamu |
|
|
8 |
3 |
p. 785-796 |
artikel |
35 |
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial
|
Brudno, Jennifer N. |
|
|
8 |
3 |
p. 802-814 |
artikel |
36 |
Under AI’s lens: spotting mutations visually
|
Fein, Joshua A. |
|
|
8 |
3 |
p. 827-828 |
artikel |
37 |
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma
|
Wai, Shin Hnin |
|
|
8 |
3 |
p. 736-745 |
artikel |
38 |
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML
|
Nawas, Mariam T. |
|
|
8 |
3 |
p. 553-561 |
artikel |